Skip to content

Experimental study on microcirculation perfusion of lower extremity venous ulcers evaluated by super-resolution microscopic imaging and microscopic contrast imaging

Experimental study on microcirculation perfusion of lower extremity venous ulcers evaluated by super-resolution microscopic imaging and microscopic contrast imaging

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600123782
Enrollment
Unknown
Registered
2026-04-29
Start date
2026-05-01
Completion date
Unknown
Last updated
2026-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

venous ulceration of lower extremity

Interventions

Ulcer group:None

Sponsors

The First Affiliated Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Clinical diagnosis of venous leg ulcer (CEAP classification C5 or C6), with chronic venous insufficiency of the lower extremities (e.g., deep/superficial venous reflux or obstruction) confirmed by color Doppler ultrasound (CDUS); 2.Ulcer duration >= 4 weeks; 3.Ulcer area between 1 and 25 cm^2; 4.Ability to understand and voluntarily sign the informed consent form, and commitment to complete regular follow-up visits; 5. Age >= 18 years old;

Exclusion criteria

Exclusion criteria: 1.Ankle-Brachial Index (ABI) < 0.8, or a clinically confirmed diagnosis of arterial ulcer or mixed ulcer with predominantly arterial etiology; 2.Ulcers resulting from primary non-venous etiologies such as diabetic neuropathy, pressure, trauma, vasculitis, malignancy, or infection; 3.The target ulcer has received specific treatments (e.g., advanced dressings, bioengineered skin, venous surgery, etc.) within 4 weeks prior to enrollment that may interfere with the assessment; 4.Presence of active severe infection (e.g., osteomyelitis) or exposed bone/tendon in the ulcer, requiring priority management; 5.Allergy to ultrasound contrast agents; 6.Presence of severe systemic diseases; 7.Pregnant or breastfeeding women;

Design outcomes

Primary

MeasureTime frame
Microvascular flow velocity, Blood volume,Perfusion index, Peak intensity, Area under curve (AUC), Arrival time, Time to peak (TTP);

Secondary

MeasureTime frame
CEAP classification;

Countries

China

Contacts

Public ContactHou Jiaxin

The First Affiliated Hospital of Chongqing Medical University

876452908@qq.com+86 23 89012746

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 7, 2026